Venture Capital
The capital proceeds will accelerate the clinical development of Ciraparantag.
1
Meituan buys Dingdong's China business, deepens grocery delivery push
2
Grab adds new lens to driverless fleet vision, bags distribution of AV ‘eyes’ in SEA
3
Led by Singapore, SE Asia IPOs raised $5.92b in 2025—the highest since 2022
4
C Capital buys Australia land parcel to tap logistics, data centre demand
5
India:108 BioCapital leads $20m funding in Pinwheel Therapeutics
More Stories
Singapore police to charge former Biofourmis CEO
CVC said to explore stake sale in Indonesian industrial gas firm
Affirma Capital makes first deal from energy transition fund
Singapore’s Tanglin Venture secures capital for $200m third fund
KKR-led consortium to fully acquire SG data centre firm STT GDC at $11b valuation
Deals
Peak XV invested $8m, while existing investors InfoEdge and Chiratae infused $2.5m each.
However, compared with Jan 2025, total funding fell 39.3%, while deal volume dropped 4.8%.
The funding was led by Sofina and Sauce.vc.
IPOs & Markets
CEO Jacob Aarup-Andersen said the brewer was reviewing an IPO in India.
Varaha is looking to raise a total corpus of about $45 million in its Series B round.
People
SMBC acquired a 24% stake in the Mumbai-based lender last year.
MD Ashish Agrawal and investors Ishaan Mittal and Tejeshwi Sharma have exited the firm.
Opinion
The budget improves the underlying conditions that allow healthcare businesses to be built, scaled, and financed.
The company will launch the IPO for retail investors on February 9.
